Reich Samuel J
SEC insider (Form 3/4/5 filer). CIK 0001394645. CEO at SAB Biotherapeutics, Inc. (SABS). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in MIAMI BEACH, FL.
Companies Reich Samuel J has filed insider reports for
- SAB Biotherapeutics, Inc. (SABS): Director, Officer, CEO
Reich Samuel J
CIK: 0001394645
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SABS
SAB Biotherapeutics, Inc.
DirectorOfficer